Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 59

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 59
---
 1,100 individual claims at December 31, 2024 and 2023, and estimates for potential unreported claims. The time period required to resolve these claims can vary depending upon the jurisdiction, the nature, and the form of resolution of the claims. The estimation of the timing of payments beyond a year can vary significantly. Although considerable variability is inherent in reserve estimates, management believes the reserves for losses and loss expenses are adequate; however, there can be no assurance the ultimate liability will not exceed management’s estimates.

11.Redeemable Noncontrolling Interests:

The following is a summary of the activity related to our Redeemable noncontrolling interests (in millions):For the Year Ended December 31,202420232022Balance at beginning of period$42.0 $35.6 $42.2 Net income attributable to noncontrolling interests5.1 8.3 7.2 Distributions declared(10.2)(1.1)(5.3)Contribution to joint ventures18.0 — — Change in fair value1.6 (0.8)(3.4)Other— — 0.1 Spin off of Enhabit, Inc.— — (5.2)Balance at end of period$56.5 $42.0 $35.6 

F-34

Encompass Health Corporation and SubsidiariesNotes to Consolidated Financial Statements

The following table reconciles the net income attributable to nonredeemable Noncontrolling interests, as recorded in the shareholders’ equity section of the consolidated balance sheets, and the net income attributable to Redeemable noncontrolling interests, as recorded in the mezzanine section of the consolidated balance sheets, to the Net income attributable to noncontrolling interests presented in the consolidated statements of comprehensive income (in millions):For the Year Ended December 31,202420232022Net income attributable to nonredeemable noncontrolling interests$135.8 $102.7 $87.7 Net income attributable to redeemable noncontrolling interests5.1 8.3 7.2 Net income attributable to noncontrolling interests$140.9 $111.0 $94.9 

12.Fair Value Measurements:  

Our financial assets and liabilities that are measured at fair value on a recurring basis are as follows (in millions):  Fair Value Measurements at Reporting Date UsingAs of December